Grifols, S.A. (GIKLY)
OTCMKTS · Delayed Price · Currency is USD
6.57
-0.03 (-0.45%)
At close: Feb 2, 2026
Grifols Market Cap
Grifols has a market cap or net worth of $7.84 billion as of February 12, 2026. Its market cap has increased by 44.85% in one year.
Market Cap
7.84B
Enterprise Value
21.17B
Revenue
8.82B
Ranking
n/a
PE Ratio
17.93
Stock Price
$6.57
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 931.51M to 7.84B, an increase of 741.57%. That is a compound annual growth rate of 11.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 8.11B | 5.69% |
| Dec 31, 2025 | 7.68B | 30.51% |
| Dec 31, 2024 | 5.88B | -42.36% |
| Dec 29, 2023 | 10.20B | 45.60% |
| Dec 30, 2022 | 7.01B | -36.73% |
| Dec 30, 2021 | 11.08B | -36.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Glass House Brands | 761.25M |
| Elite Pharmaceuticals | 485.68M |
| Northwest Biotherapeutics | 413.38M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| OpGen | 337.95M |
| CytoDyn | 304.50M |